Live from the NIH registry
Studies recruiting near Appleton right now
Top 25 of 143 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (24.7 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (24.7 mi)
· Sponsor: National Cancer Institute (NCI)
Quality of End-of-Life Care for Children With Cancer
Childhood Hematopoietic and Lymphatic System Neoplasm, Childhood Malignant Solid Neoplasm
N/A
Observational 2,425 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (24.7 mi)
· Sponsor: Children's Oncology Group
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Vince Lombardi Cancer Clinic - Oshkosh — Oshkosh, Wisconsin (19.1 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
HSHS St. Vincent Hospital Regional Cancer Center — Green Bay, Wisconsin (24.7 mi)
· Sponsor: Bristol-Myers Squibb
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
ThedaCare Regional Cancer Center — Appleton, Wisconsin (1.7 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Multiple Myeloma
Phase 3
Interventional 1,594 participants sought
St Vincent HSHS (Green Bay Oncology) — Green Bay, Wisconsin (24.7 mi)
· Sponsor: European Myeloma Network B.V.
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 335 participants sought
ThedaCare Regional Cancer Center — Appleton, Wisconsin (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Bionic Prosthetics & Orthotics — Green Bay, Wisconsin (24.7 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
ThedaCare Regional Cancer Center — Appleton, Wisconsin (1.7 mi)
· Sponsor: Wake Forest University Health Sciences
Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief
Neck Pain Musculoskeletal, Neck Pain Treatment
N/A
Interventional 160 participants sought
Emplify by Bellin Health Ashwaubenon — Green Bay, Wisconsin (24.7 mi)
· Sponsor: Baylor University
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (24.7 mi)
· Sponsor: National Cancer Institute (NCI)
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma
Phase 2
Interventional 227 participants sought
ThedaCare Regional Cancer Center — Appleton, Wisconsin (1.7 mi)
· Sponsor: SWOG Cancer Research Network
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
ThedaCare Regional Cancer Center — Appleton, Wisconsin (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
Integrated Cancer Repository for Cancer Research
Multiple conditions
N/A
Observational 999,999 participants sought
Bellin Memorial Hospital — Green Bay, Wisconsin (24.7 mi)
· Sponsor: University of Nebraska
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (24.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Viral Lung Infection and Acute Respiratory Failure
Phase 3
Interventional 3,527 participants sought
Research Site — Green Bay, Wisconsin (24.7 mi)
· Sponsor: AstraZeneca
Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study
Autism Spectrum Disorder, Autism
Phase 1, Phase 2
Interventional 100 participants sought
The Lyday Center — Green Bay, Wisconsin (24.7 mi)
· Sponsor: Adia Med of Winter Park LLC
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
ThedaCare Regional Cancer Center — Appleton, Wisconsin (1.7 mi)
· Sponsor: SWOG Cancer Research Network
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (24.7 mi)
· Sponsor: National Cancer Institute (NCI)
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma
N/A
Observational 800 participants sought
ThedaCare Regional Cancer Center — Appleton, Wisconsin (1.7 mi)
· Sponsor: University of Rochester
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Cardiotoxicity, HER2/Neu Positive
Phase 3
Interventional 491 participants sought
Bellin Memorial Hospital — Green Bay, Wisconsin (24.7 mi)
· Sponsor: SWOG Cancer Research Network
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,260 participants sought
ThedaCare Regional Cancer Center — Appleton, Wisconsin (1.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma
Phase 2
Interventional 46 participants sought
Vince Lombardi Cancer Clinic - Oshkosh — Oshkosh, Wisconsin (19.1 mi)
· Sponsor: National Cancer Institute (NCI)
Standardized Application of Feeding Evaluations Using SMART Tool
Infant and Young Child Feeding
N/A
Interventional 3,500 participants sought
Aurora Medical Center Oshkosh — Oshkosh, Wisconsin (19.1 mi)
· Sponsor: Wake Forest University Health Sciences